⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
prnewswire.com
AMGN
MRK
ZLAB
PHAT
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
RDHL
CPIX
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
globenewswire.com
PHAT
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PHAT
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
globenewswire.com
PHAT
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
globenewswire.com
PHAT
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
PHAT
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
PHAT
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
PHAT